PSAA-216: STRENGTHEN HIV/AIDS PREV., CARE, TREATMENT REF. SRVS. TARG. MSM

$1,120,000U62FY2009PSCDC

Promoteurs Objectif Zerosida, Port-Au-Prince

Investigators

Eddy Genececontact

View original record on NIH RePORTER →